Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA 5-FU CTRPv2 pan-cancer AAC 0.017 0.6
mRNA MG-132 CTRPv2 pan-cancer AAC -0.03 0.6
mRNA avicin D CTRPv2 pan-cancer AAC 0.026 0.6
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.026 0.6
mRNA L-685458 CCLE pan-cancer AAC -0.022 0.6
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC -0.033 0.7
Download CSV